Prot# SHP621-301:Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) with Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study

Project: Research project

Project Details

StatusFinished
Effective start/end date4/12/16 → 4/12/21

Funding

  • PPD Development (SHP621-301)
  • Shire ViroPharma Incorporated (SHP621-301)